Once-weekly HIV pill performs as well as daily treatment in phase III study

Researchers found that a once-weekly tablet combining islatravir and lenacapavir performed as well as the once-daily bictegravir–emtricitabine–tenofovir alafenamide regimen.

Going gluten-free doesn't fully reset gut bacteria in celiac kids, new study finds

Drinking to cope with stress may permanently rewire your brain

Stress-driven drinking in early adulthood may permanently rewire the brain, leaving lasting cognitive effects even after years of abstinence.